35Pharma
Gilles Tremblay has extensive experience in the pharmaceutical industry, currently holding the position of Vice President Preclinical Development at 35Pharma. Prior to this, Gilles has held various leadership roles at companies such as HyperMabs Inc., Forbius, Alethia Biotherapeutics Inc., and SignalGene Inc. Tremblay holds a PhD in Biochemistry and Molecular Biology from McGill University.
This person is not in any offices
35Pharma
Biopharmaceutical company that designs and develops biologics for pulmonary hypertension & musculoskeletal disorders.